Advanced search
Publication Cover
Acta Oncologica Volume 52, 2013 - Issue 1
Journal homepage
2,957
Views
65
CrossRef citations to date
0
Altmetric
Original Articles

Prognostic impact of FOXP3 expression in triple-negative breast cancer

Soohyeon LeeDivision of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea
,
Eun Yoon ChoDepartment of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
,
Yeon Hee ParkDivision of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, KoreaCorrespondence[email protected]
,
Jin Seok AhnDivision of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea
&
Young-Hyuck ImDivision of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea
Pages 73-81 | Received 09 Aug 2012, Accepted 12 Sep 2012, Published online: 17 Oct 2012

Citations (65)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (6)

Yiqi Fan & Shuai He. (2022) The Characteristics of Tumor Microenvironment in Triple Negative Breast Cancer. Cancer Management and Research 14, pages 1-17.
Read now
Ruibin Wang, Yuchen Li, Yanjie Zhao, Feng Shi, Quan Zhou, Jiangping Wu, Shuzhen Lyu & Qingkun Song. (2022) Metformin Inducing the Change of Functional and Exhausted Phenotypic Tumor-Infiltrated Lymphocytes and the Correlation with JNK Signal Pathway in Triple-Negative Breast Cancer. Breast Cancer: Targets and Therapy 14, pages 391-403.
Read now
Asmaa M Zahran, Omnia El-Badawy, Lamiaa M Kamel, Amal Rayan, Khalid Rezk & Mona H Abdel-Rahim. (2021) Accumulation of Regulatory T Cells in Triple Negative Breast Cancer Can Boost Immune Disruption. Cancer Management and Research 13, pages 6019-6029.
Read now
Bruna K. Banin-Hirata, Carlos E. C. de Oliveira, Roberta Losi-Guembarovski, Patricia M. M. Ozawa, Glauco A. F. Vitiello, Felipe C. de Almeida, Daniela R. Derossi, Nayara D. André & Maria A. E. Watanabe. (2018) The prognostic value of regulatory T cells infiltration in HER2-enriched breast cancer microenvironment. International Reviews of Immunology 37:3, pages 144-150.
Read now
Elisabeth Specht Stovgaard, Dorte Nielsen, Estrid Hogdall & Eva Balslev. (2018) Triple negative breast cancer – prognostic role of immune-related factors: a systematic review. Acta Oncologica 57:1, pages 74-82.
Read now
David P Boyle, Clare M McCourt, Kyle B Matchett & Manuel Salto-Tellez. (2013) Molecular and clinicopathological markers of prognosis in breast cancer. Expert Review of Molecular Diagnostics 13:5, pages 481-498.
Read now

Articles from other publishers (59)

Hirosato Tamari, Yasuhiko Kitadai, Hidehiko Takigawa, Ryo Yuge, Yuji Urabe, Fumio Shimamoto & Shiro Oka. (2023) Investigating the Role of Tumor-Infiltrating Lymphocytes as Predictors of Lymph Node Metastasis in Deep Submucosal Invasive Colorectal Cancer: A Retrospective Cross-Sectional Study. Cancers 15:21, pages 5238.
Crossref
Swati Hagone, Patil U. Bharat, Anupama Gupta & Gangane Nitin. (2023) Expression of FOXP3 of Tumor-Infiltrating Lymphocytes in Invasive Breast Cancer: Its Relationship to Histopathological Parameters and Overall Survival. I.P. Pavlov Russian Medical Biological Herald 31:2, pages 265-272.
Crossref
Gyöngyi Munkácsy, Libero Santarpia & Balázs Győrffy. (2023) Therapeutic Potential of Tumor Metabolic Reprogramming in Triple-Negative Breast Cancer. International Journal of Molecular Sciences 24:8, pages 6945.
Crossref
Yalan Sun, Ying Wang, Fang Lu, Xianghong Zhao, Zhenlin Nie & Bangshun He. (2023) The prognostic values of FOXP3+ tumor-infiltrating T cells in breast cancer: a systematic review and meta-analysis. Clinical and Translational Oncology 25:6, pages 1830-1843.
Crossref
Chun-Ming Chang & Ho Yin Pekkle Lam. (2023) Metaplastic Carcinoma of the Axillary Breast With Heterologous Mesenchymal (Chondroid) Differentiation: A Difficult Case and Literature Review. Breast Cancer: Basic and Clinical Research 17.
Crossref
Carlos Alexander Huertas-Caro, Mayra Alejandra Ramirez, Henry J. Gonzalez-Torres, María Carolina Sanabria-Salas & Silvia J. Serrano-Gómez. (2022) Immune Lymphocyte Infiltrate and its Prognostic Value in Triple-Negative Breast Cancer. Frontiers in Oncology 12.
Crossref
Elisabeth S. Stovgaard, Iben Kümler, Kamille List-jensen, Anne Roslind, Ib J. Christensen, Estrid Høgdall, Dorte Nielsen & Eva Balslev. (2022) Prognostic and Clinicopathologic Associations of LAG-3 Expression in Triple-negative Breast Cancer. Applied Immunohistochemistry & Molecular Morphology 30:1, pages 62-71.
Crossref
Caterina Fattorini, Federica Petrelli, Grazia Gallippi & Alessandro Ginori. 2022.
Tracy Z Tien, Justina N L W Lee, Jeffrey C T Lim, Xiao‐Yang Chen, Aye Aye Thike, Puay Hoon Tan & Joe P S Yeong. (2021) Delineating the breast cancer immune microenvironment in the era of multiplex immunohistochemistry/immunofluorescence. Histopathology 79:2, pages 139-159.
Crossref
Polina D. Dimitrova, Savelina L. Popovska & Ivan N. Ivanov. (2021) A Study on Tumor-Infiltrating Lymphocytes in Different Subtypes of Breast Cancer. Journal of Biomedical and Clinical Research 14:1, pages 70-81.
Crossref
Alyssa Vito, Stephanie Rathmann, Natalie Mercanti, Nader El-Sayes, Karen Mossman & John Valliant. (2021) Combined Radionuclide Therapy and Immunotherapy for Treatment of Triple Negative Breast Cancer. International Journal of Molecular Sciences 22:9, pages 4843.
Crossref
Kevin KosKarin E. de Visser. (2021) The Multifaceted Role of Regulatory T Cells in Breast Cancer. Annual Review of Cancer Biology 5:1, pages 291-310.
Crossref
Jenny Stenström, Ingrid Hedenfalk & Catharina Hagerling. (2021) Regulatory T lymphocyte infiltration in metastatic breast cancer—an independent prognostic factor that changes with tumor progression. Breast Cancer Research 23:1.
Crossref
Mona Sadeghalvad, Hamid-Reza Mohammadi-Motlagh & Nima Rezaei. (2020) Immune microenvironment in different molecular subtypes of ductal breast carcinoma. Breast Cancer Research and Treatment 185:2, pages 261-279.
Crossref
Kashif Asghar, Asif Loya, Iftikhar Ali Rana, Muhammad Abu Bakar, Asim Farooq, Muhammad Tahseen, Muhammad Ishaq, Iqra Masood & Muhammad Usman Rashid. (2020) Forkhead box P3 and indoleamine 2,3-dioxygenase co-expression in Pakistani triple negative breast cancer patients. World Journal of Clinical Oncology 11:12, pages 1018-1028.
Crossref
Emarene Kalaw, Malcolm Lim, Jamie R. Kutasovic, Anna Sokolova, Lucinda Taege, Kate Johnstone, James Bennett, Jodi M. Saunus, Colleen Niland, Kaltin Ferguson, Irma Gresshoff, Mark Bettington, Nirmala Pathmanathan, Gary M. Tse, David Papadimos, Rajadurai Pathmanathan, Gavin Harris, Rin Yamaguchi, Puay Hoon Tan, Stephen Fox, Sandra A. O’Toole, Peter T. Simpson, Sunil R. Lakhani & Amy E. McCart Reed. (2020) Metaplastic breast cancers frequently express immune checkpoint markers FOXP3 and PD-L1. British Journal of Cancer 123:11, pages 1665-1672.
Crossref
Giovanni Zarrilli, Gianluca Businello, Maria Vittoria Dieci, Silvia Paccagnella, Valentina Carraro, Rocco Cappellesso, Federica Miglietta, Gaia Griguolo, Valentina Guarneri, Marcello Lo Mele & Matteo Fassan. (2020) The Tumor Microenvironment of Primitive and Metastatic Breast Cancer: Implications for Novel Therapeutic Strategies. International Journal of Molecular Sciences 21:21, pages 8102.
Crossref
Masanori Oshi, Mariko Asaoka, Yoshihisa Tokumaru, Fernando A. Angarita, Li Yan, Ryusei Matsuyama, Emese Zsiros, Takashi Ishikawa, Itaru Endo & Kazuaki Takabe. (2020) Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Cancers 12:10, pages 3038.
Crossref
Hulya Sahin Ozkan, Mustafa Umit Ugurlu, Perran Fulden Yumuk & Handan Kaya. (2020) Prognostic Role of Immune Markers in Triple Negative Breast Carcinoma. Pathology & Oncology Research 26:4, pages 2733-2745.
Crossref
Maya Dadiani, Daniela Necula, Smadar Kahana-Edwin, Nino Oren, Tamir Baram, Irina Marin, Dana Morzaev-Sulzbach, Anya Pavlovski, Nora Balint-Lahat, Liat Anafi, Stefan Wiemann, Cindy Korner, Einav Nili Gal-Yam, Camila Avivi, Bella Kaufman, Iris Barshack & Adit Ben-Baruch. (2020) TNFR2+ TILs are significantly associated with improved survival in triple-negative breast cancer patients. Cancer Immunology, Immunotherapy 69:7, pages 1315-1326.
Crossref
Ana Catarina Urbano, Catarina Nascimento, Maria Soares, Jorge Correia & Fernando Ferreira. (2020) Clinical Relevance of the serum CTLA-4 in Cats with Mammary Carcinoma. Scientific Reports 10:1.
Crossref
Elie Dagher, Laura Simbault, Jérôme Abadie, Delphine Loussouarn, Mario Campone & Frédérique Nguyen. (2020) Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer. Tumor Biology 42:1, pages 101042831990105.
Crossref
Ling Deng, Donghao Lu, Yingnan Bai, Yanping Wang, Hong Bu & Hong Zheng. (2019) Immune Profiles of Tumor Microenvironment and Clinical Prognosis among Women with Triple-Negative Breast Cancer. Cancer Epidemiology, Biomarkers & Prevention 28:12, pages 1977-1985.
Crossref
Lin Zhang, Xiaohong Iris Wang, Jianmin Ding, Qigang Sun & Songlin Zhang. (2019) The predictive and prognostic value of Foxp3+/CD25+ regulatory T cells and PD-L1 expression in triple negative breast cancer. Annals of Diagnostic Pathology 40, pages 143-151.
Crossref
Nanna Jørgensen, Gry Persson & Thomas Vauvert F. Hviid. (2019) The Tolerogenic Function of Regulatory T Cells in Pregnancy and Cancer. Frontiers in Immunology 10.
Crossref
Xia Zhao, Yanping Li, Xiaoli Wang, Jiangping Wu, Yanhua Yuan, Shuzhen Lv & Jun Ren. (2019) Synergistic association of FOXP3+ tumor infiltrating lymphocytes with CCL20 expressions with poor prognosis of primary breast cancer. Medicine 98:50, pages e18403.
Crossref
Ning Pu, Guochao Zhao, Hanlin Yin, Jian-ang Li, Abulimiti Nuerxiati, Dansong Wang, Xuefeng Xu, Tiantao Kuang, Dayong Jin, Wenhui Lou & Wenchuan Wu. (2018) CD25 and TGF-β blockade based on predictive integrated immune ratio inhibits tumor growth in pancreatic cancer. Journal of Translational Medicine 16:1.
Crossref
Marinos Tsiatas, Konstantine T. Kalogeras, Kyriaki Manousou, Ralph M. Wirtz, Helen Gogas, Elke Veltrup, Flora Zagouri, Georgios Lazaridis, Angelos Koutras, Christos Christodoulou, George Pentheroudakis, Constantina Petraki, Dimitrios Bafaloukos, Dimitrios Pectasides, Paris Kosmidis, Epaminontas Samantas, Charisios Karanikiotis, Pavlos Papakostas, Meletios-Athanassios Dimopoulos & George Fountzilas. (2018) Evaluation of the prognostic value of CD3, CD8, and FOXP3 mRNA expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy. Cancer Medicine 7:10, pages 5066-5082.
Crossref
Padmashree Rida, Angela Ogden, Ian O. Ellis, Zsuzsanna Varga, Antonio C. Wolff, Tiffany A. Traina, Christos Hatzis, Julie R. Palmer, Christine B. Ambrosone, Brian D. Lehmann, Rita Nanda, Valerie Montgomery Rice, Otis W. Brawley, Mylin A. Torres, Emad Rakha & Ritu Aneja. (2018) First international TNBC conference meeting report. Breast Cancer Research and Treatment 169:3, pages 407-412.
Crossref
Wataru Goto, Shinichiro Kashiwagi, Yuka Asano, Koji Takada, Katsuyuki Takahashi, Takaharu Hatano, Tsutomu Takashima, Shuhei Tomita, Hisashi Motomura, Masahiko Ohsawa, Kosei Hirakawa & Masaichi Ohira. (2018) Predictive value of improvement in the immune tumour microenvironment in patients with breast cancer treated with neoadjuvant chemotherapy. ESMO Open 3:6, pages e000305.
Crossref
I-Ji Jeong, Sung-Gyu Lee, Young Hoon Kim, Beom Seok Ko, Jong Won Lee, Byung Ho Son, Se-Hyun Ahn & Hee Jeong Kim. (2017) Characteristics and prognosis of breast cancer after liver or kidney transplantation. Breast Cancer Research and Treatment 167:1, pages 101-106.
Crossref
F. Qian, Y. Qingping, W. Linquan, H. xiaojin, W. Rongshou, R. Shanshan, L. Wenjun, H. Yong & L. Enliang. (2017) High tumor-infiltrating FoxP3 + T cells predict poor survival in estrogen receptor-positive breast cancer: A meta-analysis. European Journal of Surgical Oncology (EJSO) 43:7, pages 1258-1264.
Crossref
Veronica De Rosa, Francesca Di Rella, Antonio Di Giacomo & Giuseppe Matarese. (2017) Regulatory T cells as suppressors of anti-tumor immunity: Role of metabolism. Cytokine & Growth Factor Reviews 35, pages 15-25.
Crossref
Joe Yeong, Aye Aye Thike, Jeffrey Chun Tatt Lim, Bernett Lee, Huihua Li, Siew-Cheng Wong, Susan Swee Shan Hue, Puay Hoon Tan & Jabed Iqbal. (2017) Higher densities of Foxp3+ regulatory T cells are associated with better prognosis in triple-negative breast cancer. Breast Cancer Research and Treatment 163:1, pages 21-35.
Crossref
Nanyan Rao, Jiayin Qiu, Jiannan Wu, Hong Zeng, Fengxi Su, Kaifeng Qiu, Junyan Wu & Herui Yao. (2017) Significance of Tumor-Infiltrating Lymphocytes and the Expression of Topoisomerase IIα in the Prediction of the Clinical Outcome of Patients with Triple-Negative Breast Cancer after Taxane-Anthracycline-Based Neoadjuvant Chemotherapy. Chemotherapy 62:4, pages 246-255.
Crossref
DianaP Saraiva, M. Guadalupe Cabral, António Jacinto & Sofia Braga. (2017) How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment. ESMO Open 2:4, pages e000208.
Crossref
Samantha Burugu, Karama Asleh-Aburaya & Torsten O. Nielsen. (2016) Immune infiltrates in the breast cancer microenvironment: detection, characterization and clinical implication. Breast Cancer 24:1, pages 3-15.
Crossref
Elena Sanmartín, Fernando Ortiz-Martínez, Eloy Pomares-Navarro, Araceli García-Martínez, Montserrat Rodrigo-Baños, Marta García-Escolano, Leire Andrés, Enrique Lerma, Francisco I. Aranda, Pascual Martínez-Peinado, José M. Sempere-Ortells & Gloria Peiró. (2016) CD44 induces FOXP3 expression and is related with favorable outcome in breast carcinoma. Virchows Archiv 470:1, pages 81-90.
Crossref
Jiafeng Shou, Zhigang Zhang, Yucheng Lai, Zhigang Chen & Jian Huang. (2016) Worse outcome in breast cancer with higher tumor-infiltrating FOXP3+ Tregs : a systematic review and meta-analysis. BMC Cancer 16:1.
Crossref
Wenjing Tian, Le Wang, Lili Yuan, Wenming Duan, Wenhui Zhao, Shuhuai Wang & Qingyuan Zhang. (2016) A prognostic risk model for patients with triple negative breast cancer based on stromal natural killer cells, tumor‐associated macrophages and growth‐arrest specific protein 6. Cancer Science 107:7, pages 882-889.
Crossref
Fernando Ortiz-Martínez, Francisco José Gutiérrez-Aviñó, Elena Sanmartín, Eloy Pomares-Navarro, Cristina Villalba-Riquelme, Araceli García-Martínez, Enrique Lerma & Gloria Peiró. (2016) Association of Notch pathway down-regulation with Triple Negative/Basal-like breast carcinomas and high tumor-infiltrating FOXP3 + Tregs. Experimental and Molecular Pathology 100:3, pages 460-468.
Crossref
Marina B. Stenina, E. V Tsareva, A. A Zharov & S. A Tyulyandin. (2016) Tumor infiltrating lymphocytes: biological essence and clinical significance in breast cancer. Russian Journal of Oncology 21:1-2, pages 92-100.
Crossref
Yan Mao, Qing Qu, Xiaosong Chen, Ou Huang, Jiayi Wu & Kunwei Shen. (2016) The Prognostic Value of Tumor-Infiltrating Lymphocytes in Breast Cancer: A Systematic Review and Meta-Analysis. PLOS ONE 11:4, pages e0152500.
Crossref
Hirofumi Matsumoto, Aye Aye Thike, Huihua Li, Joe Yeong, Si-lin Koo, Rebecca Alexandra Dent, Puay Hoon Tan & Jabed Iqbal. (2016) Increased CD4 and CD8-positive T cell infiltrate signifies good prognosis in a subset of triple-negative breast cancer. Breast Cancer Research and Treatment 156:2, pages 237-247.
Crossref
Maryann Kwa & Sylvia Adams. (2016) Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in Breast Cancer. Current Breast Cancer Reports 8:1, pages 1-13.
Crossref
Qing-Kun Song, Jun Ren, Xin-Na Zhou, Xiao-Li Wang, Guo-Hong Song, Li-Jun Di, Jing Yu, Amy Hobeika, Michael A. Morse, Yan-Hua Yuan, Hua-Bing Yang & Herbert Kim Lyerly. (2015) The prognostic value of peripheral CD4+CD25+ T lymphocytes among early stage and triple negative breast cancer patients receiving dendritic cells-cytokine induced killer cells infusion. Oncotarget 6:38, pages 41350-41359.
Crossref
Daqing Jiang, Zhaohua Gao, Zhengang Cai, Meixian Wang & Jianjun He. (2015) Clinicopathological and prognostic significance of FOXP3+ tumor infiltrating lymphocytes in patients with breast cancer: a meta-analysis. BMC Cancer 15:1.
Crossref
Murugan Kalimutho, Kate Parsons, Deepak Mittal, J. Alejandro López, Sriganesh Srihari & Kum Kum Khanna. (2015) Targeted Therapies for Triple-Negative Breast Cancer: Combating a Stubborn Disease. Trends in Pharmacological Sciences 36:12, pages 822-846.
Crossref
Hirofumi Matsumoto, Si-lin Koo, Rebecca Dent, Puay Hoon Tan & Jabed Iqbal. (2015) Role of inflammatory infiltrates in triple negative breast cancer: Table 1. Journal of Clinical Pathology 68:7, pages 506-510.
Crossref
Alberto Ocaña, Laura Diez-Gónzález, Encarna Adrover, Antonio Fernández-Aramburo, Atanasio Pandiella & Eitan Amir. (2015) Tumor-Infiltrating Lymphocytes in Breast Cancer: Ready for Prime Time?. Journal of Clinical Oncology 33:11, pages 1298-1299.
Crossref
Sathana Dushyanthen, Peter Savas, Karen Willard-Gallo, Carsten Denkert, Roberto Salgado & Sherene Loi. (2015) Tumour-Infiltrating Lymphocytes (TILs) in Breast Cancer: a Predictive or a Prognostic Marker?. Current Breast Cancer Reports 7:1, pages 59-70.
Crossref
John Stagg & Sherene Loi. 2015. Cancer Immunology. Cancer Immunology 457 470 .
Shuzhen Liu, William D Foulkes, Samuel Leung, Dongxia Gao, Sherman Lau, Zuzana Kos & Torsten O Nielsen. (2014) Prognostic significance of FOXP3+ tumor-infiltrating lymphocytes in breast cancer depends on estrogen receptor and human epidermal growth factor receptor-2 expression status and concurrent cytotoxic T-cell infiltration. Breast Cancer Research 16:5.
Crossref
Dammy Pinheiro, Yu-Mei Chang, Hannah Bryant, Balazs Szladovits, Tim Dalessandri, Lucy J. Davison, Elizabeth Yallop, Emily Mills, Chiara Leo, Ana Lara, Anneliese Stell, Gerry Polton & Oliver A. Garden. (2014) Dissecting the Regulatory Microenvironment of a Large Animal Model of Non-Hodgkin Lymphoma: Evidence of a Negative Prognostic Impact of FOXP3+ T Cells in Canine B Cell Lymphoma. PLoS ONE 9:8, pages e105027.
Crossref
Ke Pan, Xun-Xing Guan, Yong-Qiang Li, Jing-Jing Zhao, Jian-Jun Li, Hui-Juan Qiu, De-Sheng Weng, Qi-Jing Wang, Qing Liu, Li-Xi Huang, Jia He, Shi-Ping Chen, Miao-La Ke, Yi-Xin Zeng & Jian-Chuan Xia. (2014) Clinical Activity of Adjuvant Cytokine-Induced Killer Cell Immunotherapy in Patients with Post-Mastectomy Triple-Negative Breast Cancer. Clinical Cancer Research 20:11, pages 3003-3011.
Crossref
Leandra Fiori Lopes, Roberta Losi Guembarovski, Alda Losi Guembarovski, Marina Okuyama Kishima, Clodoaldo Zago Campos, Julie Massayo Maeda Oda, Carolina Batista Ariza, Karen Brajão de Oliveira, Sueli Donizete Borelli & Maria Angelica Ehara Watanabe. (2014) FOXP3 Transcription Factor : A Candidate Marker for Susceptibility and Prognosis in Triple Negative Breast Cancer . BioMed Research International 2014, pages 1-7.
Crossref
Maria Isabel Carvalho, Isabel Pires, Justina Prada & Felisbina L. Queiroga. (2014) A Role for T-Lymphocytes in Human Breast Cancer and in Canine Mammary Tumors. BioMed Research International 2014, pages 1-11.
Crossref
Chandan Verma, Jennifer M Eremin, Adrian Robins, Andrew J Bennett, Gerard P Cowley, Mohamed A El-Sheemy, Jibril A Jibril & Oleg Eremin. (2013) Abnormal T regulatory cells (Tregs: FOXP3+, CTLA-4+), myeloid-derived suppressor cells (MDSCs: monocytic, granulocytic) and polarised T helper cell profiles (Th1, Th2, Th17) in women with large and locally advanced breast cancers undergoing neoadjuvant chemotherapy (NAC) and surgery: failure of abolition of abnormal treg profile with treatment and correlation of treg levels with pathological response to NAC. Journal of Translational Medicine 11:1.
Crossref
Lutfiye Demir, Seyran Yigit, Hulya Ellidokuz, Cigdem Erten, Isil Somali, Yuksel Kucukzeybek, Ahmet Alacacioglu, Suna Cokmert, Alper Can, Murat Akyol, Ahmet Dirican, Vedat Bayoglu, Aysegul Akder Sari & Mustafa Oktay Tarhan. (2013) Predictive and prognostic factors in locally advanced breast cancer: effect of intratumoral FOXP3+ Tregs. Clinical & Experimental Metastasis 30:8, pages 1047-1062.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.